Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Harrington Discovery Institute

Showing   of 10 results

lung and heart monitoring during exercise

Discovery of Protein S-nitrosylation Leads to Creation of Oxygen and Nitric Oxide Exercise Monitor

Jonathan Stamler, MD discusses what lead him to the discover of S-nitrosylation, the binding of nitric oxide to proteins works through allostery and how this all lead to the creation of an oxygen and nitric oxide tracking fitness monitor.

Therapeutic drug testing

UH and CWRU Biotech Startup Rodeo Therapeutics Corp. Sold to Amgen Inc.

Drug at heart of deal, developed in Cleveland, could make recovery from bone marrow transplant quicker and safer, among other applications - Innovations in Cancer | Summer 202

What's New in Research at University Hospitals in Cleveland, Ohio

Approach to discovery spans basic science to clinical impact - UH Alumni Associations e-Newsletter | September 2020

Harrington Discovery Institute Issues Transatlantic Call for Proposals to Treat Coronavirus and its Clinical Impact

Philanthropic drug development program seeks to accelerate treatments into human clinical trials - UH News Release

Harrington Discovery Institute at University Hospitals to Aid in Global Fight Against Coronavirus Pandemic

Initiative will advance therapies for treating Coronavirus and future deadly viruses - UH News Release

HARRINGTON SCHOLAR-INNOVATOR AWARD

FUNDING OPPORTUNITY

Harrington Discovery Institute at University Hospitals Announces 2020 Scholar Innovator Award Recipients

Six physician-scientists from the U.S. and Canada selected for drug development grant - UH News Release | 12/19/2019

The University of Oxford and Harrington Discovery Institute at University Hospitals Announce New Affiliation to Advance Therapies for Rare Diseases

Joint program combines capabilities to improve treatment options globally for patients with rare diseases - Press Release February 28, 2019

Results are loading...